<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05041192</url>
  </required_header>
  <id_info>
    <org_study_id>21-004746</org_study_id>
    <nct_id>NCT05041192</nct_id>
  </id_info>
  <brief_title>The Effects of Synaquell on Brain Function</brief_title>
  <official_title>The Effect of Synaquell on Objective Brain Function Measures in Ice Hockey Players</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HealthTech Connex Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thorne Research Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the dietary supplement, Synaquell (TM), for&#xD;
      effects on brain function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ice Hockey players will be administered Synaquell over the course of one season. Each player&#xD;
      will be administered Synaquell or a placebo twice, daily. They will be tested during the&#xD;
      preseason and the postseason to compare changes in cognitive measures. This is an optimal&#xD;
      population, as Synaquell was designed for contact sport athletes and others sustaining&#xD;
      frequent head impacts.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 3, 2021</start_date>
  <completion_date type="Anticipated">May 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in brain vital signs</measure>
    <time_frame>Baseline, Postseason (approximately 6 months)</time_frame>
    <description>Obtained by EEG recording of N100, P300, N400 amplitudes and latencies. Increased amplitudes are indicative of larger signals and increased latencies are indicative of slower responses.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in blood biomarker</measure>
    <time_frame>Baseline, Postseason (approximately 6 months)</time_frame>
    <description>Neurofilament light chain (NfL) blood serum levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in King-Devick Test (KDT) scores</measure>
    <time_frame>Baseline, Postseason (approximately 6 months)</time_frame>
    <description>A rapid number-naming test that requires individuals to read 3 numbered cards a loud as fast as possible, the resulting time is the KDT score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Synaquell Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive the dietary supplement, Synaquell, twice-daily during the hockey season.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will receive the placebo twice-daily, during the hockey season.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Synaquell</intervention_name>
    <description>15.8 grams of Synaquell are mixed with 10 ounces of water two times per day and consumed.</description>
    <arm_group_label>Synaquell Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>15.8 grams of a placebo (that looks, smells, and tastes like Synaquell) are mixed with 10 ounces of water two times per day and consumed.</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or greater.&#xD;
&#xD;
          -  Fluent English speakers.&#xD;
&#xD;
          -  Medically cleared to play ice hockey.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An allergy to the ingredients of Synaquell or Synaquell+ (Magnesium, beta&#xD;
             hydroxybutyrate, Glutathione, N-acetyl-L-cysteine, Riboflavin, Magnesium, Leucine,&#xD;
             Isoleucine, Valine, Resveratrol, Curcumin Phytosome, Nicotinamide riboside,&#xD;
             Docosahexanoic Acid).&#xD;
&#xD;
          -  Clinically documented hearing issues.&#xD;
&#xD;
          -  In-ear hearing aid or cochlear implant.&#xD;
&#xD;
          -  Implanted pacemaker or defibrillator.&#xD;
&#xD;
          -  Metal or plastic implants in skull.&#xD;
&#xD;
          -  Lack of verbal fluency in the English language.&#xD;
&#xD;
          -  History of seizures.&#xD;
&#xD;
          -  Allergy to rubbing alcohol or EEG gel.&#xD;
&#xD;
          -  Unhealthy scalp.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael J Stuart, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2021</study_first_submitted>
  <study_first_submitted_qc>September 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2021</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Michael J. Stuart</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ice Hockey</keyword>
  <keyword>Cognitive Function</keyword>
  <keyword>Cognition</keyword>
  <keyword>Brain</keyword>
  <keyword>Supplement</keyword>
  <keyword>Contact Sport Athletes</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

